ACE inhibitors
The Valsartan in Heart Failure Trial       (Val-HeFT) has been designed to test the efficacy and safety of the AT(1)       receptor blocker (ARB) valsartan in combination with ACE inhibitors and all other       prescribed therapies in patients with heart failure.
The Valsartan in Heart Failure Trial       (Val-HeFT) has been designed to test the efficacy and safety of the AT(1)       receptor blocker (ARB) valsartan in combination with  @SUBJECT$  and all other       prescribed therapies  @PREDICAT$   @OBJECT$  with heart failure.